NuVasive (NUVA) Misses Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- Lula, Brazil's iconic working class president, wins historic fourth term in dramatic comeback
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Accenture shares fall on insider sales and analyst downgrade
- Wall Street closes lower to end rocky week
- Credo Technology shares fall on competition concerns
Credit Suisse Positive on NuVasive (NUVA), 'Momentum Improving, Driven by Critical Mass of New Products and Growth Drivers', Street High PT $75
February 24, 2022 2:15 PM ESTCredit Suisse analyst Matt Miksic lowered the price target on NuVasive (NASDAQ: NUVA) to $75.00 (from $83.00) while maintaining a Outperform rating.
The analyst comments "Spine Momentum Results in a Better-Than-Expected Finish, Despite COVID and Staffing Challenges: Mgmts strategy combining new and innovative product launches and enabling technology showed solid results in terms of... More



